NEWSLETTER SIGN UP

IN: Devices, Pharmaceuticals

Approved in March 2013, Invokana (canagliflozin) is an SGLT2 Inhibitor used to treat adults with Type 2 diabetes, manufactured by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. SGLT2 inhibitors work by preventing high blood sugar by helping the patient’s kidneys remove excess sugar through their urine. In May 2015, the U.S. Food and Drug Administration (FDA) issued a warning the drug has been linked to cases of ketoacidosis, a serious condition where there is too much acid in the blood. Complications of diabetic ketoacidosis include difficulty breathing, nausea/vomiting, abdominal pain, confusion and unusual fatigue or sleepiness. The condition can lead to diabetic coma and/or death.

Carden Legal Services has developed a network of trusted attorneys and law firms to help you get the help you deserve. You and your loved ones may not know you have a claim in the above area. Let us assist you with evaluating your potential claim and determine if you are due compensation for your injury or damages.